Nintedanib ameliorates animal model of dermatitis.

Heo, Min-Jeong; Lee, Chanmi; Choi, Soo Young; Choi, Yeong Min; An, In-Sook; Bae, Seunghee; An, Sungkwan; Jung, Jin Hyuk

Heo, Min-Jeong; Lee, Chanmi; Choi, Soo Young; Choi, Yeong Min; An, In-Sook; Bae, Seunghee; An, Sungkwan; Jung, Jin Hyuk.

Afiliación

Heo MJ; Korea Institute of Dermatological Science, GeneCellPharm Corporation, 375 Munjeong 2(i)-dong, Songpa-gu, Seoul, 05836, South Korea.
Lee C; Korea Institute of Dermatological Science, GeneCellPharm Corporation, 375 Munjeong 2(i)-dong, Songpa-gu, Seoul, 05836, South Korea.
Choi SY; Korea Institute of Dermatological Science, GeneCellPharm Corporation, 375 Munjeong 2(i)-dong, Songpa-gu, Seoul, 05836, South Korea.
Choi YM; Korea Institute of Dermatological Science, GeneCellPharm Corporation, 375 Munjeong 2(i)-dong, Songpa-gu, Seoul, 05836, South Korea.
An IS; Korea Institute of Dermatological Science, GeneCellPharm Corporation, 375 Munjeong 2(i)-dong, Songpa-gu, Seoul, 05836, South Korea.
Bae S; Research Institute for Molecular-Targeted Drugs, Department of Cosmetics Engineering, Konkuk University, Seoul, 05029, South Korea.
An S; Research Institute for Molecular-Targeted Drugs, Department of Cosmetics Engineering, Konkuk University, Seoul, 05029, South Korea. ansungkwan@konkuk.ac.kr.
Jung JH; Korea Institute of Dermatological Science, GeneCellPharm Corporation, 375 Munjeong 2(i)-dong, Songpa-gu, Seoul, 05836, South Korea. jungjh@skinreseach.or.kr.

Sci Rep ; 10(1): 4493, 2020 03 11.

Article en En | MEDLINE | ID: mdl-32161331

Asunto(s)

Dermatitis/tratamiento farmacológico; Dermatitis/metabolismo; Indoles/farmacología; Inhibidores de Proteínas Quinasas/farmacología; Animales; Biomarcadores; Biopsia; Línea Celular; Supervivencia Celular; Dermatitis/etiología; Dermatitis/patología; Modelos Animales de Enfermedad; Ensayo de Inmunoadsorción Enzimática; Expresión Génica; Inmunoglobulina E/sangre; Inmunoglobulina E/inmunología; Ratones; Oxazolona/efectos adversos; Piel/efectos de los fármacos; Piel/metabolismo; Piel/patología; Receptor 1 de Factores de Crecimiento Endotelial Vascular/genética; Receptor 1 de Factores de Crecimiento Endotelial Vascular/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Dermatitis / Indoles Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google